Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Yearly performance of total market index funds provides a broad view of winners and laggards. Use these insights to adjust your exposure today.
28,320 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
When tech giants join forces, investors take notice. This article breaks down the huge news nebius stock and why Meta...
A grounded, practical look at whether Micron Technology stock can move meaningfully in the next 12 months. Explore dr...
A CEO’s drastic HR purge and a high-profile EEOC lawsuit against The New York Times collide at a moment of market vol...
Could Sandisk stock reach jaw-dropping levels next year? This article breaks down the logic, the risks, and practical...
Energy refuses quit: stocks keep leading gains into June 2026, with the XLE ETF rising and major oil names driving th...
Is Palantir stock undervalued stock? This in-depth guide breaks down the AI growth case, valuation angles, and how to...
A leading market strategist says fears about AI are overblown as investors rotate into buy opportunities beyond megac...
A value-driven, catalyst-led small-cap approach is drawing attention as investors seek mispriced names with clear ups...
As tensions flare, Qatar’s plan to buy $4 billion in Patriot missiles reshapes security and markets. This article bre...
A high-profile crypto promoter known as Bitcoin Rodney pleaded guilty in a case that exposed a global $1.8 billion fr...